|
|
||||||||
Eur J Cardiothorac Surg 2005;28:659-660
© 2005 Elsevier Science NL
Letter to the Editor |
Department of Cardiac Surgery and Thoracic Transplantation, Teheran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Boulvard, Teheran, Iran
Received 29 May 2005; accepted 27 June 2005.
* Corresponding author. Fax: +98 21 69 29 977. (Email: mathias.aazami{at}laposte.net).
Key Words: Myocardial revascularisation On-pump Off-pump Atrial fibrillation
As it could be expected, the retrospective clinical trial of Dr Enc et al. [1], aimed to investigate the difference in the postoperative incidence of atrial fibrillation (AF) between Off-pump and On-pump aorto-coronary grafting (ACG), is followed by a reply from Dr Raja [2] embellished with the scholarly statistical recalls. We agree with both authors in that the final answer will be brought about by a prospective randomised multi-centre trial, hence the intricate nature of various factors implicated in the occurrence of post-ACG atrial fibrillation makes its design difficult, if not possible, to be ruled by.
In addition to already recognised factors involved in, we would emphasise that the onset of new iatrogenic perfusion following ACG, deemed as aorto-coronary perfusion, can be a factor in the occurrence of AF as a unique pathophysiological pathway by inducing functional atrial ischemia. Although calling for being investigated, it is our belief that the incidence of postoperative AF would be the same in its entirety as the final product of both On-pump and Off-pump procedures is represented by aorto-coronary perfusion.
By opening the epicardial arteries that are functionally separated from systemic circulation, ACG sets up occurrence of systolic coronary perfusion disturbances, especially the onset of an early systolic retrograde flow into the graft, known classically as the competition flow, importance of which is inversely related to the degree of recipient artery stenosis [3]. As atrial perfusion occurs during the systole (the atrial diastole) [4], one can speculate that the latter could result in functional atrial mal-perfusion, playing as a substratum for AF. Yet, considering the increased sensitivity of the senile atrial myocardium to ischemia, the latter might elucidate why the age is recognised as the most powerful risk factor for postoperative AF.
Accordingly, many covered biases can be implicated in raising AF incidence with On-pump ACG:
When our pathophysiological pathway proves to be well founded, then the debate will centre hardly upon being skeptic towards reliability of Off-pump procedures, but from a rational point of view, the ongoing challenge would be rather how to achieve coronary revascularisation with arterial grafts able to resume systolic coronary perfusion as in the native epicardial arteries. Such an achievement, however, sounds to appear unconceivable with Off-pump procedures.
In conclusion, it is plain that if all possible involving pathophysiological pathways are not yet investigated carefully, therefore, even the current best available evidence can be called into the question.
References
This article has been cited by other articles:
![]() |
S. G. Raja Reply to Aazami and SalehiBias in surgical randomised controlled trials can be minimized but not eliminated Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 661 - 661. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |